Carlisle Cos. Inc. (CSL)

108.00
NYSE : Producer Manufacturing
Prev Close 107.64
Day Low/High 107.17 / 108.68
52 Wk Low/High 92.09 / 119.21
Avg Volume 479.20K
Exchange NYSE
Shares Outstanding 60.95M
Market Cap 6.56B
EPS 5.80
P/E Ratio 18.72
Div & Yield 1.48 (1.37%)

Latest News

Carlisle Companies Declares Regular Quarterly Dividend

Carlisle Companies Declares Regular Quarterly Dividend

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.

Patient Advocacy Groups Focus On Key Issues Affecting Patients

Five patient advocacy organizations are awarded LEAD Grants to support their advocacy initiatives in 2018.

Carlisle Companies Reports Record First Quarter 2018 Revenues

Carlisle Companies Reports Record First Quarter 2018 Revenues

Carlisle Companies Incorporated (NYSE:CSL) reported record revenues of $984.7 million for the first quarter of 2018, a 27.

CSL Behring, Leader In Rare Diseases, Showcases Innovations In Neuromuscular Medicine (NMM) At The 2018 American Academy Of Neurology Annual Meeting

- CSL Behring will host an industry therapeutic update highlighting findings from the PATH trial, the largest clinical trial in CIDP, and present key poster presentations featuring advances in the field of NMM

The Lancet Publishes Results Demonstrating Adjuvanted Quadrivalent Influenza Vaccine Provides Significantly Greater Efficacy In Children 6 Through 23 Months

- Study demonstrates that adjuvanted quadrivalent influenza vaccine provides 31% greater relative efficacy in preventing influenza in children 6 through 23 months compared to conventional influenza vaccine.

Carlisle Companies Incorporated To Announce First Quarter 2018 Results On April 24, 2018

Carlisle Companies Incorporated To Announce First Quarter 2018 Results On April 24, 2018

Carlisle Companies Incorporated (NYSE:CSL) will release first quarter 2018 results on Tuesday, April 24, 2018 after the market closes.

Carlisle Companies Incorporated Completes Sale Of Carlisle FoodService Products

Carlisle Companies Incorporated Completes Sale Of Carlisle FoodService Products

Carlisle Companies Incorporated (NYSE:CSL) announced today that it has completed the sale of Carlisle FoodService Products to The Jordan Company of New York, NY, for cash at an enterprise value of $750 million.

Forbes Magazine Names CSL Limited Among Top 50 Employers In The World

Forbes Magazine Names CSL Limited Among Top 50 Employers In The World

Global biotech leader rated at no. 42 for Patient Focus, Innovation, and Sustainable Growth

FDA Approves Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) For The Treatment Of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

FDA Approves Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) For The Treatment Of Patients With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

First and only subcutaneous immunoglobulin (SCIg) approved for the treatment of CIDP based on the largest controlled clinical study in CIDP

CSL Behring Receives Patient Impact Award For Subcutaneous Prophylactic Treatment To Prevent Hereditary Angioedema Attacks

CSL Behring Receives Patient Impact Award For Subcutaneous Prophylactic Treatment To Prevent Hereditary Angioedema Attacks

Life Sciences Pennsylvania recognized CSL Behring's commitment to patients for its novel subcutaneous C1 esterase inhibitor, HAEGARDA®, to prevent swelling caused by the rare genetic disorder

CSL CEO Paul Perreault Calls On Industry To Improve Patients' Access To Medicines

CSL CEO Paul Perreault Calls On Industry To Improve Patients' Access To Medicines

- Industry's role in ensuring access to medicine is an imperative, not an afterthought

Carlisle Companies Reports Record Full Year And Fourth Quarter Net Sales

Carlisle Companies Reports Record Full Year And Fourth Quarter Net Sales

Carlisle Companies Incorporated (NYSE:CSL) reported record fourth quarter 2017 net sales of $1,071.

What's Behind the Hound of Hades' Stock Market Rampage

What's Behind the Hound of Hades' Stock Market Rampage

The free market is going to take back control of interest rates.

Carlisle Companies Incorporated Authorizes Repurchase Of An Additional 5 Million Shares

Carlisle Companies Incorporated Authorizes Repurchase Of An Additional 5 Million Shares

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) today announced a new share repurchase program that authorizes management to buy back up to an additional 5 million shares of the company's common stock...

Carlisle Companies Incorporated Declares Regular Quarterly Dividend

Carlisle Companies Incorporated Declares Regular Quarterly Dividend

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.

Carlisle Companies Incorporated To Sell Carlisle FoodService Products

Carlisle Companies Incorporated To Sell Carlisle FoodService Products

Carlisle Companies Incorporated (NYSE:CSL) today announced the signing of a definitive agreement to sell Carlisle FoodService Products (CFS) to The Jordan Company of New York, NY, for $750 million in cash, subject to...

Carlisle Companies Incorporated To Announce 4th Quarter Results On February 8, 2018

Carlisle Companies Incorporated To Announce 4th Quarter Results On February 8, 2018

Carlisle Companies Incorporated (NYSE:CSL) will release fourth quarter 2017 results on Thursday, February 8, 2018 after the market closes.

Carlisle Companies Incorporated Elects Jesse Singh To Board Of Directors

Carlisle Companies Incorporated Elects Jesse Singh To Board Of Directors

Carlisle Companies Incorporated (NYSE: CSL) announced today that Jesse Singh, Chief Executive Officer of CPG International, has been elected to its Board of Directors, effective immediately.

Ford, Cadence Systems, Carlisle, Teledyne: 'Mad Money' Lightning Round

Ford, Cadence Systems, Carlisle, Teledyne: 'Mad Money' Lightning Round

Jim Cramer's bullish on Ford Motor, Cadence Systems, Carlisle, Teledyne, McDonald's.

What to Worry About for 2018: Cramer's 'Mad Money' Recap (Wednesday 12/6/17)

What to Worry About for 2018: Cramer's 'Mad Money' Recap (Wednesday 12/6/17)

Go ahead, call Jim Cramer a worry wart. But he wants investors to be prepared for anything. Here's his list of the Top 10 Investment Worries for 2018.

CSL Behring Advances To Phase 3 Cardiovascular Outcomes Trial For CSL112, Its Novel Apolipoprotein A-I (Human) Infusion Therapy

CSL Behring Advances To Phase 3 Cardiovascular Outcomes Trial For CSL112, Its Novel Apolipoprotein A-I (Human) Infusion Therapy

Study to evaluate CSL112 for the reduction of early, recurrent cardiovascular events in heart attack survivors

Be FLUent Partnership Shines Spotlight On Importance Of Flu Prevention In Seniors

Be FLUent Partnership Shines Spotlight On Importance Of Flu Prevention In Seniors

Seqirus partners with American Nurse Practitioner Foundation, American Pharmacists Association and Physician Assistant Foundation to drive conversation around flu prevention in adults 65 and older

Carlisle Companies Incorporated Announces Completion Of $1 Billion Senior Notes Offering

Carlisle Companies Incorporated Announces Completion Of $1 Billion Senior Notes Offering

Carlisle Companies Incorporated (NYSE:CSL) announced today that it has successfully closed an underwritten public offering of $1,000,000,000 aggregate principal amount of senior notes, consisting of $400,000,000 aggregate...

Carlisle Companies Incorporated Declares Regular Quarterly Dividend

Carlisle Companies Incorporated Declares Regular Quarterly Dividend

The Board of Directors of Carlisle Companies Incorporated (NYSE:CSL) has declared a dividend of $0.

Carlisle Companies To Present At Baird Industrial Conference

Carlisle Companies To Present At Baird Industrial Conference

Carlisle Companies Incorporated (NYSE:CSL) announced today that D.

TheStreet Quant Rating: B (Buy)